The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus
Open accessAbstract
Complete resolution of an acute inflammatory response and its return to homeostasis are essential for healthy tissues. Here, we overview ongoing efforts to characterize cellular and molecular mechanisms that govern the resolution of self‐limited inflammation. Systematic temporal analyses of evolving inflammatory exudates using mediator lipidomics‐informatics, proteomics, and cellular trafficking with murine resolving exudates demonstrate novel endogenous pathways of local‐acting mediators that share both anti‐inflammatory and pro‐resolving properties. In murine systems, resolving‐exudate leukocytes switch their phenotype to actively generate new families of mediators from major omega‐3 fatty acids EPA and DHA termed resolvins and protectins. Recent advances on their biosynthesis and actions are reviewed with a focus on the E‐series resolvins (RvE1, RvE2), D series resolvins (RvD1, RvD2) and the protectins including neuro protectin D1/protectin D1 (NPD1/PD1) as well as their aspirin‐triggered epimeric forms. Members of each new family demonstrate potent stereo‐specific actions, joining the lipoxins as endogenous local signals that govern resolution and endogenous anti‐inflammation mechanisms. In addition to their origins and roles in resolution biology in the immune system, recent findings indicate that these new mediator families also display potent protective actions in lung, kidney, and eye as well as enhance microbial clearance. Thus, these endogenous agonists of resolution pathways constitute a novel genus of chemical mediators that possess pro‐resolving, anti‐inflammatory, and antifibrotic as well as host‐directed antimicrobial actions. These may be useful in the design of new therapeutics and treatments for diseases with the underlying trait of uncontrolled inflammation and redox organ stress. British Journal of Pharmacology (2008) 153, S200–S215; doi:10.1038/sj.bjp.0707489; published online 29 October 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,843
Ranade, V. V. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31817c941f · Cited by 2,775
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · cited 1×
“…such as atherosclerosis (Libby, 2002), cancer (Coussens and Werb, 2002), asthma (Barnes, 1999), autoimmune disease, and various neuropathological disorders including stroke, Alzheimer’s and Parkinson’s diseases (Majno and Joris, 1996; Nathan, 2002; Erlinger et al., 2004; Hansson et al., 2006).”
BackgroundResolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Self-citationLeukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Self-citation(1999) · PubMed · Cited by 2,062
Robbins pathologic basis of disease
Cotran, R. S., Kumar, V., & Collins, T. (1989) · Medical Entomology and Zoology · Cited by 1,944
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationImmune cell migration in inflammation: present and future therapeutic targets
Luster, A. D., Alon, R., & von Andrian, U. H. (2005) · Nature Immunology · doi:10.1038/ni1275 · Cited by 1,313
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311 · cited 1×
“In view of the compelling results from the GISSI study, which showed improvements in 411 000 cardiovascular patients, that is, reduction in the incidents of sudden death to B45% in those taking almost 1 g of o-3 per day (GISSI-Prevenzione Investigators, 1999; Marchioli et al., 2002).”
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationA NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET
Burr, G. O., & Burr, M. M. (1929) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)78281-5 · Cited by 1,185
Resolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,184
Self-citationINFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg-Nauclér, C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,046
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045 · cited 7×
“…2005) and a firm consensus of the cellular, molecular and tissue events and precise terms defining resolution from leading scholars in the area (Serhan et al., 2007), we may find this new genus of pro-resolving agonists of resolution to be a useful therapeutic approach to treat many diseases…”
BackgroundInfluentialSelf-citationHong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000 · cited 14×
“…et al., 2004; Lukiw et al., 2005) have documented the formation of NPD1 in neural tissues and identified its potent immunomodulatory actions (Serhan et al., 2002, 2006a; Hong et al., 2003) and neuroprotective actions (Marcheselli et al., 2003; Mukherjee et al., 2004; Lukiw et al., 2005) (Table 5).”
BackgroundMethodInfluentialSelf-citationSerhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Self-citationArita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 922
Self-citationMechanisms of action of docosahexaenoic acid in the nervous system
Salem, N., Litman, B., Kim, H., & Gawrisch, K. (2001) · Lipids · doi:10.1007/s11745-001-0805-6 · Cited by 919 · cited 2×
“…actions of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the major omega-3 PUFA, remains a topic of interest and considerable discussion (Lands, 1987; Bazan, 1990; Simopoulos et al., 1999; Salem et al., 2001) because structure–activity relationships remained to be established.”
BackgroundLukiw, W. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25420 · Cited by 872
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Self-citationInflammatory Resolution: new opportunities for drug discovery
Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1383 · Cited by 772
Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., & Bazan, N. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402531101 · Cited by 753 · cited 8×
“NPD1 limits stroke brain injury in part by reducing the entry of activated PMN to the stroke area (Marcheselli et al., 2003) and retinal pigmented cellular damage and promotes brain cell survival, suppressing Ab42-induced neurotoxicity (Mukherjee et al., 2004) (Table 5).”
InfluentialClària, J., & Serhan, C. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9475 · Cited by 700
Self-citationMolecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins
Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., & Serhan, C. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4345 · Cited by 699
Self-citationConnor, K. M., SanGiovanni, J. P., Lofqvist, C., Aderman, C. M., Chen, J., Higuchi, A., Hong, S., Pravda, E. A., Majchrzak, S., Carper, D., et al. (2007) · Nature Medicine · doi:10.1038/nm1591 · Cited by 688
Self-citationOn the Specificity of the Oxygenation of Unsaturated Fatty Acids Catalyzed by Soybean Lipoxidase
Hamberg, M., & Samuelsson, B. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99432-9 · Cited by 656
Borgeat, P., Hamberg, M., & Samuelsson, B. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57008-9 · Cited by 641
Arita, M., Ohira, T., Sun, Y.-P., Elangovan, S., Chiang, N., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3912 · Cited by 633
Self-citationIKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation
Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V., & Karin, M. (2005) · Nature · doi:10.1038/nature03491 · Cited by 626
Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., & Serhan, C. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409271102 · Cited by 590
Self-citationResolvin D1 and Its Aspirin-triggered 17R Epimer
Sun, Y.-P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., & Serhan, C. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609212200 · Cited by 537
Self-citationC-Reactive Protein and the Risk of Incident Colorectal Cancer
Erlinger, T. P. (2004) · JAMA · doi:10.1001/jama.291.5.585 · Cited by 533
Robbins Pathologic Basis of Disease
Chejfec, G. (1999) · Archives of Pathology and Laboratory Medicine · doi:10.5858/1999-123-859a-rpbod · Cited by 515
Rossi, A. G., Sawatzky, D. A., Walker, A., Ward, C., Sheldrake, T. A., Riley, N. A., Caldicott, A., Martinez-Losa, M., Walker, T. R., Duffin, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1468 · Cited by 509
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Self-citationSerhan, C. N., Gotlinger, K., Hong, S., Lu, Y., Siegelman, J., Baer, T., Yang, R., Colgan, S. P., & Petasis, N. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1848 · Cited by 455
Self-citationSerhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.002 · Cited by 454
Self-citationPerretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm786 · Cited by 447
Self-citationRvE1 protects from local inflammation and osteoclastmediated bone destruction in periodontitis
Hasturk, H., Kantarci, A., Ohira, T., Arita, M., Ebrahimi, N., Chiang, N., Petasis, N. A., Levy, B. D., Serhan, C. N., & Van Dyke, T. E. (2006) · The FASEB Journal · doi:10.1096/fj.05-4724fje · Cited by 435
Self-citationTakano, T., Fiore, S., Maddox, J. F., Brady, H. R., Petasis, N. A., & Serhan, C. N. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1693 · Cited by 431
Self-citationSerhan, C. N., Jain, A., Marleau, S., Clish, C., Kantarci, A., Behbehani, B., Colgan, S. P., Stahl, G. L., Merched, A., Petasis, N. A., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6856 · Cited by 404
Self-citationWorkshop on the Essentiality of and Recommended Dietary Intakes for Omega-6 and Omega-3 Fatty Acids
Simopoulos, A. P., Leaf, A., & Salem, N. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718888 · Cited by 362
Protectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness
Levy, B. D., Kohli, P., Gotlinger, K., Haworth, O., Hong, S., Kazani, S., Israel, E., Haley, K. J., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.496 · Cited by 359
Self-citationMulti-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4
Levy, B. D., De Sanctis, G. T., Devchand, P. R., Kim, E., Ackerman, K., Schmidt, B. A., Szczeklik, W., Drazen, J. M., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm748 · Cited by 352
Self-citationDefective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
Karp, C. L., Flick, L. M., Park, K. W., Softic, S., Greer, T. M., Keledjian, R., Yang, R., Uddin, J., Guggino, W. B., Atabani, S. F., et al. (2004) · Nature Immunology · doi:10.1038/ni1056 · Cited by 344
Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury
Duffield, J. S., Hong, S., Vaidya, V. S., Lu, Y., Fredman, G., Serhan, C. N., & Bonventre, J. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5902 · Cited by 334
Self-citationDesign of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human Neutrophils
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., & Madara, J. L. (1995) · Biochemistry · doi:10.1021/bi00044a041 · Cited by 327
Self-citationGronert, K., Maheshwari, N., Khan, N., Hassan, I. R., Dunn, M., & Laniado Schwartzman, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410638200 · Cited by 310
Libby, P. (2002) · Scientific American · doi:10.1038/scientificamerican0502-46 · Cited by 304
Cells, tissues, and disease : principles of general pathology
Majno, G., & Joris, I. (1996) · Cited by 303
Maddox, J. F., & Serhan, C. N. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.137 · Cited by 294
Self-citationMitchell, S., Thomas, G., Harvey, K., Cottell, D., Reville, K., Berlasconi, G., Petasis, N. A., Erwig, L., Rees, A. J., Savill, J., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032417.73640.72 · Cited by 287 · cited 2×
“demonstrating anti-inflammatory and pro-resolving actions in vivo (Mitchell et al., 2002; Kieran et al., 2004), a proof of concept was established, namely, that treatment with a”
BackgroundLipoxin biosynthesis and its impact in inflammatory and vascular events
Serhan, C. N. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90185-6 · Cited by 273
Self-citationLee, T. H., Mencia-Huerta, J. M., Shih, C., Corey, E. J., Lewis, R. A., & Austen, K. F. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111612 · Cited by 270
Maddox, J. F., Hachicha, M., Takano, T., Petasis, N. A., Fokin, V. V., & Serhan, C. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6972 · Cited by 266
Self-citationChiang, N., Bermudez, E. A., Ridker, P. M., Hurwitz, S., & Serhan, C. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405445101 · Cited by 266
Self-citationGewirtz, A. T., Collier-Hyams, L. S., Young, A. N., Kucharzik, T., Guilford, W. J., Parkinson, J. F., Williams, I. R., Neish, A. S., & Madara, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5260 · Cited by 256
Ariel, A., Li, P.-L., Wang, W., Tang, W.-X., Fredman, G., Hong, S., Gotlinger, K. H., & Serhan, C. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509796200 · Cited by 246
Self-citationSerhan, C. N. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00001-4 · Cited by 241
Self-citationTjonahen, E., Oh, S. F., Siegelman, J., Elangovan, S., Percarpio, K. B., Hong, S., Arita, M., & Serhan, C. N. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.011 · Cited by 239
Self-citationPaul-Clark, M. J., van Cao, T., Moradi-Bidhendi, N., Cooper, D., & Gilroy, D. W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040566 · Cited by 236
Henson, P. M. (2005) · Nature Immunology · doi:10.1038/ni1205-1179 · Cited by 234
Takano, T., Clish, C. B., Gronert, K., Petasis, N., & Serhan, C. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1578 · Cited by 230
Self-citationTherapeutic strategies for allergic diseases
Barnes, P. J. (1999) · Nature · doi:10.1038/35037026 · Cited by 228
Chiang, N., Gronert, K., Clish, C. B., O’Brien, J. A., Freeman, M. W., & Serhan, C. N. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7016 · Cited by 218
Self-citationClish, C. B., O’Brien, J. A., Gronert, K., Stahl, G. L., Petasis, N. A., & Serhan, C. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8247 · Cited by 212
Self-citationPouliot, M., Clish, C. B., Petasis, N. A., Van Dyke, T. E., & Serhan, C. N. (2000) · Biochemistry · doi:10.1021/bi992551b · Cited by 207
Self-citationCampbell, E. L., Louis, N. A., Tomassetti, S. E., Canny, G. O., Arita, M., Serhan, C. N., & Colgan, S. P. (2007) · The FASEB Journal · doi:10.1096/fj.07-8473com · Cited by 205
Self-citationSerhan, C. N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00047-3 · Cited by 205
Self-citationHachicha, M., Pouliot, M., Petasis, N. A., & Serhan, C. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1923 · Cited by 199
Self-citationSerhan, C. N. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0695-8 · Cited by 175
Self-citationLipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing
Svensson, C. I., Zattoni, M., & Serhan, C. N. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061826 · Cited by 175
Self-citationBirnbaum, Y., Ye, Y., Lin, Y., Freeberg, S. Y., Nishi, S. P., Martinez, J. D., Huang, M.-H., Uretsky, B. F., & Perez-Polo, J. R. (2006) · Circulation · doi:10.1161/circulationaha.106.629907 · Cited by 173
Metabolic Inactivation of Resolvin E1 and Stabilization of Its Anti-inflammatory Actions
Arita, M., Oh, S. F., Chonan, T., Hong, S., Elangovan, S., Sun, Y.-P., Uddin, J., Petasis, N. A., & Serhan, C. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603766200 · Cited by 165
Self-citationA NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET
BURR, G. O., & BURR., M. M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1973.tb06008.x · Cited by 161
The Effects of Lipoxin A 4 on Airway Responses in Asthmatic Subjects
Christie, P. E., Spur, B. W., & Lee, T. H. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1281 · Cited by 158
Fierro, I. M., Kutok, J. L., & Serhan, C. N. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.385 · Cited by 158
Self-citationArita, M., Clish, C. B., & Serhan, C. N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.181 · Cited by 153
Self-citationFiorucci, S., Wallace, J. L., Mencarelli, A., Distrutti, E., Rizzo, G., Farneti, S., Morelli, A., Tseng, J., Suramanyam, B., Guilford, W. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404722101 · Cited by 147
Leonard, M. O., Hannan, K., Burne, M. J., Lappin, D. W. P., Doran, P., Coleman, P., Stenson, C., Taylor, C. T., Daniels, F., Godson, C., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000015795.74094.91 · Cited by 145
Bannenberg, G. L., Moussignac, R., Gronert, K., Devchand, P. R., Schmidt, B. A. R., Guilford, W. J., Bauman, J. G., Subramanyam, B., Perez, H. D., Parkinson, J. F., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705912 · Cited by 140
Self-citationBandeira‐Melo, C., Serra, M. F., Diaz, B. L., Cordeiro, R. S. B., Silva, P., Lenzi, H. L., Bakhle, Y. S., Serhan, C. N., & Martins, M. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1029 · Cited by 135
Self-citationMaddox, B. K., Keene, D. R., Sakai, L. Y., Charbonneau, N. L., Morris, N. P., Ridgway, C. C., Boswell, B. A., Sussman, M. D., Horton, W. A., Bächinger, H. P., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30993 · Cited by 134
Samuelsson, B. O. (1983) · Bioscience Reports · doi:10.1007/bf01133779 · Cited by 129
Wada, K., Arita, M., Nakajima, A., Katayama, K., Kudo, C., Kamisaki, Y., & Serhan, C. N. (2006) · The FASEB Journal · doi:10.1096/fj.06-5809com · Cited by 129
Self-citationProceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids
Eicosanoids, & Lands, W. E. M. (1987) · AOCS Publishing eBooks · Cited by 127
Hong, S., Lu, Y., Yang, R., Gotlinger, K. H., Petasis, N. A., & Serhan, C. N. (2006) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2006.09.002 · Cited by 127
Self-citationProstaglandins, bioassay and inflammation
Flower, R. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706506 · Cited by 120
Jin, S., Zhang, L., Lian, Q.-Q., Liu, D., Wu, P., Yao, S., & Ye, D. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000252414.00363.c4 · Cited by 114
Levy, B. D., Lukacs, N. W., Berlin, A. A., Schmidt, B. A. R., Guilford, W. J., Serhan, C. N., & Parkinson, J. F. (2007) · The FASEB Journal · doi:10.1096/fj.07-8653com · Cited by 110
Self-citationScalia, R. G., Gefen, J., Petasis, N. A., Serhan, C. N., & Lefer, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9967 · Cited by 104
Self-citationAn Aspirin-Triggered Lipoxin A4 Stable Analog Displays a Unique Topical Anti-Inflammatory Profile
Schottelius, A. J. G., Giesen, C., Asadullah, K., Fierro, I. M., Colgan, S. P., Bauman, J. G., Guilford, W., Perez, H. D., & Parkinson, J. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.7063 · Cited by 99
Lipoxins: Potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease
Kieran, N. E., MADERNA, P., & Godson, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00487.x · Cited by 97
A novel rat lipoxin A4 receptor that is conserved in structure and function
Chiang, N., Takano, T., Arita, M., Watanabe, S., & Serhan, C. N. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705220 · Cited by 93
Self-citationOxidation of docosahexaenoic acid by rat liver microsomes.
VanRollins, M., BAKER, R. C., Sprecher, H. W., & Murphy, R. C. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91081-1 · Cited by 92
Maddox, J. F., Colgan, S. P., Clish, C. B., Petasis, N. A., Fokin, V. V., & Serhan, C. N. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.6.487 · Cited by 91
Self-citationAdventures and excursions in bioassay: the stepping stones to prostacyclin
Vane, J. R. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb10020.x · Cited by 90
Hong, S., Tjonahen, E., Morgan, E. L., Lu, Y., Serhan, C. N., & Rowley, A. F. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.04.004 · Cited by 87
Self-citationGuilford, W. J., Bauman, J. G., Skuballa, W., Bauer, S. M., Wei, G. P., Davey, D., Schaefer, C. J., Mallari, C. R., Terkelsen, J., Tseng, J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030569l · Cited by 80
Romano, M., Maddox, J. F., & Serhan, C. N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2149 · Cited by 79
Self-citationReich, E. E., Zackert, W. E., Brame, C. J., Chen, Y., Roberts, L. J., Hachey, D. L., Montine, T. J., & Morrow, J. D. (2000) · Biochemistry · doi:10.1021/bi992000l · Cited by 79
Inflammation and cancer: a failure of resolution?
Lawrence, T. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.003 · Cited by 78
Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins
Petasis, N. A., Akritopoulou‐Zanze, I., Fokin, V. V., Bernasconi, G., Keledjian, R., Yang, R., Uddin, J., Venkata, K. C. N., & Serhan, C. N. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.020 · Cited by 76
Self-citationLes Prix Nobel : Nobel Prizes, presentations, biographies and lectures
Nobelstiftelsen (1982) · Almqvist & Wiksell International eBooks · Cited by 70
Mediator-lipidomics: databases and search algorithms for PUFA-derived mediators
Lu, Y., Hong, S., Tjonahen, E., & Serhan, C. N. (2005) · Journal of Lipid Research · doi:10.1194/jlr.d400020-jlr200 · Cited by 70
Self-citationA magic bullet for mucosal protection…and aspirin is the trigger!
Wallace, J. L., & Fiorucci, S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00166-4 · Cited by 64
First total synthesis of 7(S),16(R),17(S)-Resolvin D2, a potent anti-inflammatory lipid mediator
Rodríguez, A. R., & Spur, B. W. (2004) · Tetrahedron Letters · doi:10.1016/j.tetlet.2004.09.129 · Cited by 63
Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes
Sawmynaden, P., & Perretti, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.179 · Cited by 51
Commentary: Engineering of Tissue Healing and Regeneration
Lumelsky, N. L. (2007) · Tissue Engineering · doi:10.1089/ten.2007.0100 · Cited by 50
Lipoxygenation of Docosahexaenoic Acid by the Rat Pineal Body
Sawazaki, S., Salem, N., & Kim, H. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62062437.x · Cited by 49
The role of aspirin-triggered lipoxins in the mechanism of action of aspirin
Gilroy, D. W. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.007 · Cited by 48
Clish, C. B., Sun, Y., & Serhan, C. N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5841 · Cited by 46
Self-citationAdventures and Excursions in Bioassay: The Stepping Stones to Prostacylin
Vane, J. R. (2004) · Bioscience Reports · doi:10.1007/s10540-005-2734-7 · Cited by 46
Lipid Mediator Informatics-Lipidomics: Novel Pathways in Mapping Resolution
Serhan, C. N., Hong, S., & Lü, Y. (2006) · The AAPS Journal · doi:10.1007/bf02854899 · Cited by 44
Self-citationAspirin and steroids: new mechanistic findings and avenues for drug discovery
Gilroy, D. W., & Perretti, M. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.02.006 · Cited by 42
MADERNA, P., & Godson, C. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.004 · Cited by 38
5-Lipoxygenase Upregulation by Dexamethasone in Human Mast Cells
Colamorea, T., Paola, R. D., Macchia, F., Guerrese, M.-C., Tursi, A., Butterfield, J. H., Caiaffa, M. F., Haeggström, J. Z., & Macchia, L. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1732 · Cited by 36
Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation
Hashimoto, A., Murakami, Y., Kitasato, H., Hayashi, I., & Endo, H. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.06.023 · Cited by 36
Uz, T., Dwivedi, Y., Qeli, A., Peters-Golden, M. L., Pandey, G. N., & Manev, H. (2001) · The FASEB Journal · doi:10.1096/fj.00-0836fje · Cited by 35
Devchand, P. R., Schmidt, B. A. R., Primo, V., Zhang, Q., Arnaout, M. A., Serhan, C. N., & Nikolic, B. (2005) · The FASEB Journal · doi:10.1096/fj.04-2565com · Cited by 34
Self-citationLipid Mediator Informatics and Proteomics in Inflammation-Resolution
Lu, Y., Hong, S., Gotlinger, K. H., & Serhan, C. N. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.118 · Cited by 34
Self-citationCells, Tissues, and Disease: Principles of General Pathology
Sommers, S. C. (1997) · JAMA · doi:10.1001/jama.1997.03540380084041 · Cited by 33
Wu, S., Wu, X.-H., Liao, P., & Dong, L. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.12.006 · Cited by 32
Serhan, C. N. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.07.001 · Cited by 23
Self-citationThe Resolution of Inflammation
Rossi, A. G., & Sawatsky, D. A. (2008) · Inflammopharmacology · doi:10.1007/s10787-008-1625-5 · Cited by 16
Tong, M., & Tai, H. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00039-2 · Cited by 13
Lipid Mediator Informatics-Lipidomics: Novel Pathways in Mapping Resolution
Serhan, C. N., Hong, S., & Lu, Y. (2006) · The AAPS Journal · doi:10.1208/aapsj080233 · Cited by 12
Self-citation
Cited by
Inflammatory and immune pathways in the pathogenesis of periodontal disease
Cekici, A., Kantarci, A., Hasturk, H., & Van Dyke, T. E. (2014) · Periodontology 2000 · doi:10.1111/prd.12002 · Cited by 1,415
“have similar biologic activity to lipoxins (215, 243).”
BackgroundAnti-inflammatory Agents: Present and Future
Dinarello, C. A. (2010) · Cell · doi:10.1016/j.cell.2010.02.043 · Cited by 1,095
GPX4 at the crossroads of lipid homeostasis and ferroptosis
Forcina, G. C., & Dixon, S. J. (2019) · PROTEOMICS · doi:10.1002/pmic.201800311 · Cited by 1,025
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Self-citationInflammation and Lipid Signaling in the Etiology of Insulin Resistance
Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 935
Metadata
- Authors
- Serhan, C. N., & Chiang, N.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-03
- Volume
- 153
- Issue
- S1
- Pages
- S200-15
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2107104127
- Cited by
- 431
- References
- 132
- FWCI
- 22.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.